In PAH patients with BMPR2 mutation, genes and metabolites involved in glycolysis, fatty acid pathways, and the TCA cycle are significantly increased in circulation: We sought to understand how these metabolic changes identified in the failing RV were reflected in the plasma. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.